Mona Perry, MD
Family Medicine · Clio, MINPI 1508968264
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,025 and has fallen 98.4% since, to $16 in 2023.
Across 97 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$269
- Pfizer$170
- Boehringer Ingelheim$163
- Amgen$152
- Novo Nordisk$138
- Novartis$129
- plus $548 from 17 others
What the payments were for
- Food & beverage$1,48194%
- Education$886%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 19 | $269 |
| Pfizer | 14 | $170 |
| Boehringer Ingelheim | 9 | $163 |
| Amgen | 5 | $152 |
| Novo Nordisk | 10 | $138 |
| Novartis | 7 | $129 |
| Johnson & Johnson | 5 | $72 |
| Astellas Pharma US Inc | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $60 |
| Genentech USA, Inc. | 1 | $55 |
| Lilly USA, LLC | 3 | $37 |
| Abbott | 2 | $34 |
| Pacira Therapeutics, Inc. | 2 | $34 |
| Radius Health, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Smith+Nephew | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| AstraZeneca | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
How this compares
$1,569 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $31,165 |
| EliquisApixaban | 22 | $27,881 |
| MounjaroTirzepatide | 22 | $26,429 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $24,241 |
| XareltoRivaroxaban | 12 | $18,627 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $17,091 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $12,065 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,558 |
| Atorvastatin Calcium | 137 | $2,247 |
| Levothyroxine Sodium | 121 | $1,813 |
| Metoprolol Succinate | 67 | $1,656 |
| Tamsulosin Hcl | 49 | $1,602 |
| Losartan Potassium | 104 | $1,581 |
| Omeprazole | 65 | $1,233 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $1,186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $269 | $36,30649 claims |
| Novo NordiskOzempic | $138 | $31,16518 claims |
| PfizerEliquis | $170 | $27,88122 claims |
| Lilly USA, LLCMounjaro | $37 | $26,42922 claims |
| Johnson & JohnsonXarelto | $72 | $18,62712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Clio
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.